Shenkman Capital Management Inc has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $102 Million distributed in 126 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Invesco ETF Tr Ii Sr Ln ETF with a value of $56.4M, Ishares Tr Broad Usd High Yiel with a value of $18.3M, Lending Tree, Inc. with a value of $11.8M, Spdr Bloomberg Short Term High with a value of $7.05M, and Altice Usa, Inc. with a value of $4.79M.
Examining the 13F form we can see an increase of $55.6M in the current position value, from $46M to 102M .
Shenkman Capital Management Inc is based out at New York, NY
Below you can find more details about Shenkman Capital Management Inc portfolio as well as his latest detailed transactions.
Portfolio value
$102 Million
ETFs: $81.7 Million
Financial Services: $11.8 Million
Communication Services: $8.07 Million
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 394.6%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 88.73%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 39.67%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 99.49%
-
$0
0.0% of portfolio
-
Q1 2025
Added 7.74%
Summit Midstream Corporation
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 53.24%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 43.51%
-
$0
0.0% of portfolio
-
Q1 2025
Added 22.61%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 83.03%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 64.48%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 0.37%
-
$0
0.0% of portfolio
-
Q1 2025
Added 1,637.5%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 71.05%
-
$0
0.0% of portfolio
-
Q1 2025
Added 4.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 80.64%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 41.69%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 34.62%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 23.42%
-
$0
0.0% of portfolio
-
Q1 2025
Added 21.57%
Envista Holdings Corporation
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 10.75%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 71.82%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 12.68%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 57.21%
-
$0
0.0% of portfolio
-
Q1 2025
New
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 46.31%
Amphastar Pharmaceuticals In
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 83.74%
-
$0
0.0% of portfolio
-
Q1 2025
Added 36.18%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 92.12%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 8.76%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 85.76%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 98.34%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 39.36%
-
$0
0.0% of portfolio
-
Q1 2025
Added 0.4%
-
$0
0.0% of portfolio
-
Q1 2025
Added 459.84%
-
$0
0.0% of portfolio
-
Q1 2025
Added 66.83%
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Added 1.59%
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 55.8%